The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients
Changes in body composition are associated with chemotherapy-related toxicities and effectiveness of treatment. It is hypothesized that the pharmacokinetics (PK) of chemotherapeutics may depend on body composition. The effects of body composition on the variability of paclitaxel PK were studied in p...
Saved in:
Main Authors: | Leni van Doorn (Author), Marie-Rose B. S. Crombag (Author), Hánah N. Rier (Author), Jeroen L. A. van Vugt (Author), Charlotte van Kesteren (Author), Sander Bins (Author), Ron H. J. Mathijssen (Author), Mark-David Levin (Author), Stijn L. W. Koolen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
by: Ruben A. G. van Eerden, et al.
Published: (2021) -
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021) -
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020) -
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors
by: Ruben A. G. van Eerden, et al.
Published: (2021) -
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen
by: Lena Klopp-Schulze, et al.
Published: (2020)